New antivirals are required to prevent rising antimicrobial resistance from replication inhibitors. The aim
of this study was to analyse the range of emerging mutations in herpesvirus by whole genome deep sequencing. We tested human herpesvirus 6 treatment with novel antiviral K21, where evidence indicated distinct effects on virus envelope proteins.